Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study is to obtain information about the safety and tolerability of BIIF
1149 BS45 (single dose: 40, 65, 100 mg), to determine the pharmacologically active dose
(range) by performing a citric acid challenge test and to obtain preliminary pharmacokinetic
data.